Article info

PDF

Research paper
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

Authors

  1. Correspondence to Dr Stephen D Silberstein, Jefferson Headache Center, 8130 Gibbon Building, 111 South 11th St., Philadelphia, PA 19107, USA; Stephen.Silberstein{at}jefferson.edu
View Full Text

Citation

Silberstein SD, Dodick DW, Aurora SK, et al
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

Publication history

  • Received October 31, 2013
  • Revised September 24, 2014
  • Accepted October 10, 2014
  • First published December 12, 2014.
Online issue publication 
August 13, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.